Challenges Facing the Field of Dermatology: An Interview with Dr. Daniel Siegel
Daniel Siegel MDNext Steps in Derm author and Derm In-Review Advisory Council member, Dr. Cula Dautriche, reached out to Dr. Daniel Siegel, former president of the American Academy of Dermatology (AAD), to shed some light on some of the challenges facing the field of dermatology today. Dr. Siegel is currently the chair of the Council on Corporate, Community and Philanthropic Relations of the AAD and remains heav …
Daniel Siegel MD
A Must-Read: The Business of Dermatology
Business intellect, a vital aspect of managing a practice, is not taught in residency. From the infancy of their training, dermatologists are trained to think broadly and scrupulously, using each clue, each corporeal sense, and each available tool to accurately diagnose and manage a plethora of cutaneous conditions. After residency, dermatologists set out armed with the knowledge and drive to deli …
Coronavirus & Alopecia Reporting Database
coronavirus alopecia databaseEPI Health has graciously supported the COVID-19 News and Resource Center. SECURE-Alopecia is a physician-entered patient registry to record COVID-19 positive alopecia patient outcomes, on or off treatment, with scarring and non-scarring alopecia. Clinicians worldwide are encouraged to report ALL cases of COVID-19 in their alopecia patients treated with antimalarials, JAK inhibitors (given the …
coronavirus alopecia database
April JDD Issue Highlights
April JDDHere are the issue highlights and Editor Picks for the April issue of JDD: Dermatologists respond regarding the impact of COVID-19 and examine the potential impact of drugs on susceptibility and severity of infection in Is the Coronavirus (COVID-19) Pandemic an Indication to Temporarily Modify Dermatological Management Plans?   Treatment of Plaque Psoriasis With an Excimer Laser Utilizing a …
April JDD
Hydroxychloroquine, Pentoxifylline, and Colchicine: Off-Label is ON in Dermatology
Hydroxychloroquine, Pentoxifylline, and Colchicine: Off-Label is ON in Dermatology!So many diseases, so few FDA approved indications. Between the mind-numbing time and cost from bench to bottle, it is no surprise that dermatologists, as masters of the integument are the off-label bandits, marrying their wealth of knowledge on the pathophysiology of skin diseases to the mechanisms by which medications work to create an evidenced-based armament of therapies for both common and rar …
Hydroxychloroquine, Pentoxifylline, and Colchicine: Off-Label is ON in Dermatology!
error

Enjoy this blog? Please spread the word :)